Published on 29 Aug 2022 on Simply Wall St. via Yahoo Finance
The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. Unfortunately the Surmodics, Inc. (NASDAQ:SRDX) share price slid 48% over twelve months. That falls noticeably short of the market decline of around 18%. We note that it has not been easy for shareholders over three years, either; the share price is down 32% in that time. Furthermore, it's down 19% in about a quarter. That's not much fun for holders.
Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business.
See our latest analysis for Surmodics